DK455780A - Praeparat og udstyr til afsloering af cancerceller samt fremgangsmaade til cancercelleafsloering - Google Patents

Praeparat og udstyr til afsloering af cancerceller samt fremgangsmaade til cancercelleafsloering

Info

Publication number
DK455780A
DK455780A DK455780A DK455780A DK455780A DK 455780 A DK455780 A DK 455780A DK 455780 A DK455780 A DK 455780A DK 455780 A DK455780 A DK 455780A DK 455780 A DK455780 A DK 455780A
Authority
DK
Denmark
Prior art keywords
hcg
derivatives
antibody
antibody composition
procedure
Prior art date
Application number
DK455780A
Other languages
Danish (da)
English (en)
Inventor
S W Burchiel
D R Crockford
B A Rhodes
Original Assignee
University Patents Inc
Nuc Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc, Nuc Med Inc filed Critical University Patents Inc
Publication of DK455780A publication Critical patent/DK455780A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Supports For Pipes And Cables (AREA)
  • Medicinal Preparation (AREA)
DK455780A 1979-10-29 1980-10-28 Praeparat og udstyr til afsloering af cancerceller samt fremgangsmaade til cancercelleafsloering DK455780A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/089,153 US4311688A (en) 1979-10-29 1979-10-29 Composition and method for cancer detection in humans

Publications (1)

Publication Number Publication Date
DK455780A true DK455780A (da) 1981-04-30

Family

ID=22215979

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455780A DK455780A (da) 1979-10-29 1980-10-28 Praeparat og udstyr til afsloering af cancerceller samt fremgangsmaade til cancercelleafsloering

Country Status (13)

Country Link
US (2) US4311688A (de)
EP (1) EP0028092B1 (de)
JP (1) JPS5695119A (de)
AT (1) ATE28569T1 (de)
AU (1) AU6377280A (de)
BR (1) BR8006935A (de)
CA (1) CA1152431A (de)
DE (1) DE3071996D1 (de)
DK (1) DK455780A (de)
FI (1) FI803381L (de)
IL (1) IL60780A (de)
NO (1) NO803213L (de)
ZA (1) ZA805813B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4855126A (en) * 1980-07-10 1989-08-08 Chembiomed Ltd. Method to detect T-antigen delayed hypersensitivity
WO1983001004A1 (en) * 1981-09-28 1983-03-31 Roberto Luis Ceriani Specific mammary gland labelling
US4584268A (en) * 1981-10-13 1986-04-22 Ceriani Roberto Luis Method and compositions for carcinoma diagnosis
FR2515046B1 (fr) * 1981-10-27 1985-11-29 Hybritech Inc Anticorps monoclonaux marques par un radionucleide et leur application a la visualisation d'une tumeur
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
GB2122641B (en) * 1982-06-07 1986-08-06 Otto A Gansow Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
US4624846A (en) * 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
ATE61000T1 (de) * 1983-07-29 1991-03-15 Milton David Goldenberg Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
US4782840A (en) * 1984-03-02 1988-11-08 Neoprobe Corporation Method for locating, differentiating, and removing neoplasms
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US4674480A (en) * 1984-05-25 1987-06-23 Lemelson Jerome H Drug compositions and methods of applying same
US4665897A (en) * 1984-05-25 1987-05-19 Lemelson Jerome H Composition and method for detecting and treating cancer
JPS6117065A (ja) * 1984-07-04 1986-01-25 Mitsui Toatsu Chem Inc ヒト絨毛性ゴナドトロピンの測定試薬
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4826672A (en) * 1985-06-07 1989-05-02 President And Fellows Of Harvard College Astatinated organic compounds
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
GB8519457D0 (en) * 1985-08-02 1985-09-11 Faulk Ward Page Tumour imaging agents
EP0252951A4 (de) * 1986-01-06 1988-09-07 Univ Melbourne Technetium-antikörper konjugate.
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US4762701A (en) * 1986-10-31 1988-08-09 Smithkline Beckman Corporation In vivo cellular tracking
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US5084266A (en) * 1988-02-03 1992-01-28 The University Of Melbourne Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US5128119A (en) * 1989-06-12 1992-07-07 Immunomedics, Inc. Methods for technetium/rhenium labeling of f(ab1)2 fragments
US5001052A (en) * 1989-02-09 1991-03-19 Wisconsin Alumni Research Foundation Immunoassay for FHAP and antibody useful therewith
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5279968A (en) * 1989-07-20 1994-01-18 Syncor International Corporation Method of labelling leucocytes with Tc-99m, d,1-HMPAO
CA2065299C (en) 1989-08-09 2001-07-24 Buck A. Rhodes Direct radiolabeling of antibodies and other proteins with technetium or rhenium
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
CA1340250C (en) * 1989-09-18 1998-12-15 Hans J. Hansen Method for rapidly radiolabeling monovalent antibody fragments with technetium
US5130129A (en) * 1990-03-06 1992-07-14 The Regents Of The University Of California Method for enhancing antibody transport through capillary barriers
US5011676A (en) * 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy
DE59207867D1 (de) * 1991-02-05 1997-02-27 Cis Bio International Saclay Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
AU4288493A (en) * 1992-05-15 1993-12-13 Mallinckrodt Medical, Inc. Method of preparing a diagnostic agent for detecting inflammations
AU4778893A (en) * 1992-07-21 1994-02-14 General Hospital Corporation, The System of drug delivery to the lymphatic tissues
US5756825A (en) * 1992-09-08 1998-05-26 Safavy; Ahmad Hydroxamic acid-based bifunctional chelating compounds
US5670132A (en) * 1994-09-20 1997-09-23 Immunomedics, Inc. Modified radioantibody fragments for reduced renal uptake
US5900377A (en) * 1997-03-03 1999-05-04 Syncor International Corporation Method for isolating and radiolabeling leukocytes for use in vivo
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
US7666609B1 (en) 1998-12-01 2010-02-23 Shanghai Cp Guojian Pharmaceutical Co. Ltd. Method and composition for diagnosis of melanocytic lesions
RU2154468C1 (ru) * 1999-11-09 2000-08-20 Родионов Сергей Юрьевич Способ получения таблеток альфа-фетопротеина
US20020117169A1 (en) 2001-02-27 2002-08-29 Kurz Daniel R. Cover and applicator for a portion of a mammalian body
DK1408106T3 (da) * 2002-10-11 2007-06-11 Sentoclone Ab Cancer immunterapi
WO2004034059A1 (en) * 2002-10-11 2004-04-22 Sentina Biotechnology Incorporated Methods for detection of breast cancer
US20050232926A1 (en) * 2003-06-06 2005-10-20 Oncomax Acquisition Corp. Antibodies specific for cancer associated antigen SM5-1 and uses thereof
CN1279056C (zh) * 2003-06-06 2006-10-11 马菁 肿瘤相关抗原sm5－1的特异性抗体及其应用
AU2004303448A1 (en) 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
EP1966370B1 (de) * 2005-12-21 2013-02-20 SentoClone International AB Verfahren zur Gewinnung von T-Lymphozyten
WO2007071410A1 (en) * 2005-12-21 2007-06-28 Sentoclone Ab Method for treating urinary bladder cancer
US8211424B2 (en) * 2005-12-21 2012-07-03 Sentoclone International Ab Method for treating malignant melanoma
US8206702B2 (en) * 2005-12-21 2012-06-26 Sentoclone International Ab Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer
EP2087152B1 (de) 2006-10-27 2015-03-11 Walfish, Paul Endometriale biomarker
US20100256464A1 (en) * 2007-05-14 2010-10-07 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
AU2009270434B2 (en) * 2008-07-18 2015-04-09 Sentoclone International Ab Composition comprising in vitro expanded T-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer
WO2012021969A1 (en) 2010-08-16 2012-02-23 Mount Sinai Hospital Markers of the male urogenital tract
US8668900B2 (en) 2011-02-15 2014-03-11 Kuwait University Cancer-imaging agent and method of radioimaging using the same
MA47111A (fr) 2016-12-22 2019-10-30 Univ Wake Forest Health Sciences Agents ciblant sirpgamma destinés à être utilisés dans le traitement du cancer
WO2022038198A1 (en) 2020-08-19 2022-02-24 Diamidex Monosaccharide compound for the labelling of cell secretion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010251A (en) * 1974-12-16 1977-03-01 Green Allan M Scanning agent composition and use in imaging liver and for biliary function
FR2310748A1 (fr) * 1975-05-15 1976-12-10 Abramovici J Procede de marquage de proteines a l'aide du technetium
US4116776A (en) * 1976-04-19 1978-09-26 International Radioimmune Systems, Inc. Diagnostic blood test and kit for detecting human chorionic gonadotropin
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
DE3004234A1 (de) * 1980-02-06 1981-08-13 Desowag-Bayer Holzschutz GmbH, 4000 Düsseldorf Wundbehandlungs-, wundverschluss- und wundschutzmittel fuer baeume
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody

Also Published As

Publication number Publication date
EP0028092B1 (de) 1987-07-29
ATE28569T1 (de) 1987-08-15
AU6377280A (en) 1981-05-07
US4311688A (en) 1982-01-19
FI803381A7 (fi) 1981-04-30
FI803381L (fi) 1981-04-30
US4478815A (en) 1984-10-23
DE3071996D1 (en) 1987-09-03
NO803213L (no) 1981-04-30
JPS5695119A (en) 1981-08-01
EP0028092A2 (de) 1981-05-06
IL60780A (en) 1984-02-29
EP0028092A3 (en) 1982-02-03
CA1152431A (en) 1983-08-23
ZA805813B (en) 1981-09-30
BR8006935A (pt) 1981-05-05
JPS6138173B2 (de) 1986-08-28

Similar Documents

Publication Publication Date Title
DK455780A (da) Praeparat og udstyr til afsloering af cancerceller samt fremgangsmaade til cancercelleafsloering
SE8206073L (sv) Tumoravbildning med radiomerkta monoklonala antikroppar
SE7707632L (sv) Forfarande for omvandling av cis-hexahydro-dibenso (b,d) pyran-9-oner till trans-hexahydro-dibenso (b,d) pyran-9-oner
BR7907419A (pt) Metodo de teste de microplaquetas logicas com gerador de sequencias de teste que efetua decisoes orientadas para os trajetos
CH516155A (de) Licht- und Wetterechtheitsprüfgerät
FR2297034B1 (de)
JPS53107853A (en) Concentration detection method of developer
ES2070488T5 (es) Procedimiento para la diagnosis de enfermedades tumorales.
ES244831U (es) Cierre hermetico para cartas de ensayo para analisis clinico
FI810007A7 (fi) Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille.
GB1482177A (en) Radioactive selenium and tellurium compounds and their use in diagnostic preparations
DK124988B (da) Fremgangsmåde til fremstilling af en brugsfærdig og lagerstabil prøveplade med serologisk diagnostiske præparater.
DK98692A (da) Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof
ES436045A1 (es) Procedimiento de obtencion de reactivos utiles en la detec- cion de la sifilis.
ATE4327T1 (de) Verfahren zur gewinnung von immunologisch aktiven enzymmarkierten konjugaten.
SE7609977L (sv) Forfaringssett for framstellning av radioaktivt merkt orgotein
JPS522485A (en) Radiation beam visible light converter
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
Clark Observation as moderator of reason and intuition in clinical training.
Prankerd et al. Electrophoresis of Human Red-Cell Stroma
GB1350295A (en) Method for the determination of pregnancy and a serodiagnostic composition therefor
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
SU481214A1 (ru) Способ определени концентраций меди
Suplisson et al. A simple method for the measurement of labelled compound incorporation into cells in culture
BLACK Tests conducted in the AEDC 16-ft transonic tunnel on a 0. 0226-scale model of the C-5 A aircraft for data correlation between three transonic wind tunnels(Tests on scale model configurations of C-5 aircraft to obtain data correlation on three transonic wind tunnels)[Final Report, 30 Dec. 1969- 20 Jan. 1970]